boswellic acid has been researched along with asiatic acid in 4 studies
Studies (boswellic acid) | Trials (boswellic acid) | Recent Studies (post-2010) (boswellic acid) | Studies (asiatic acid) | Trials (asiatic acid) | Recent Studies (post-2010) (asiatic acid) |
---|---|---|---|---|---|
227 | 15 | 147 | 289 | 3 | 232 |
6 | 0 | 5 | 289 | 3 | 232 |
Protein | Taxonomy | boswellic acid (IC50) | asiatic acid (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 5.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Hong, D; Hu, LH; Li, J; Li, JY; Shen, Q; Shi, L; Zhang, W; Zhang, YN | 1 |
Fukushima, EO; Muranaka, T; Nomura, Y; Vo, NNQ | 1 |
Gou, W; Guo, J; Hou, W; Li, Y; Liu, Q; Ning, H; Shang, H; Sun, X; Wei, H | 1 |
Chan, CY; Huang, CY; Liu, WH; Mong, MC; Yin, MC | 1 |
1 review(s) available for boswellic acid and asiatic acid
Article | Year |
---|---|
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
Topics: Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cisplatin; Cysteine Endopeptidases; Drug Resistance, Neoplasm; Female; Humans; Molecular Docking Simulation; Ovarian Neoplasms; Structure-Activity Relationship; Triterpenes | 2022 |
3 other study(ies) available for boswellic acid and asiatic acid
Article | Year |
---|---|
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus; Drugs, Chinese Herbal; Enzyme Inhibitors; Humans; Insulin; Obesity; Oleanolic Acid; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Receptor, Insulin; Structure-Activity Relationship; T-Lymphocytes | 2008 |
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
Topics: Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Humans; Lipoxygenase Inhibitors; Pentacyclic Triterpenes; Structure-Activity Relationship | 2019 |
Three pentacyclic triterpenes protect H9c2 cardiomyoblast cells against high-glucose-induced injury.
Topics: Apoptosis; Caspase 3; Cell Culture Techniques; Down-Regulation; Glucose; Humans; Myocytes, Cardiac; Pentacyclic Triterpenes; Reactive Oxygen Species; Triterpenes | 2014 |